查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1525461

全球基因體學人工智慧市場評估:按產品,技術,功能,應用,最終用戶,地區,機會,預測(2017-2031)

AI in Genomics Market Assessment, By Offering, By Technology, By Functionality, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 229 Pages | 商品交期: 3-5個工作天內

價格

全球基因組學人工智慧市場規模預計將從 2023 年的 6.336 億美元增至 2031 年的 89.1451 億美元，2024-2031 年的複合年增長率將達到 39.17%。人工智慧的進步、基因組數據生成的增加、對更快藥物開發過程的需求增加、慢性病患者數量的增加以及老年人口的擴大支持了市場的成長。人工智慧和基因組學的整合允許以準確、高效的方式分析大量數據，人工智慧演算法有助於預測疾病風險、開發有針對性的治療方法並識別基因突變，從而使醫療保健專業人員能夠提供更好的病人照護並做出決策。

對個人化醫療的需求不斷增長也是推動全球人工智慧基因組學市場成長的主要因素。基因組資訊幫助研究人員和科學家研究個體對藥物的反應，而與人工智慧的整合可以對大量數據進行高效的分析。人工智慧演算法可以幫助開發針對性治療、識別基因突變並預測疾病風險。

此外，癌症患者數量的增加也是擴大全球基因組學人工智慧市場的主要因素。National Cancer Institute估計，2024 年美國將診斷出約 2,001,140 名新癌症患者。這種增加可能有助於開發與癌症相關的藥物，這些藥物有助於抑制促使異常生長的□反應，關閉分子信號傳導途徑，並抑制負責基因表達的癌細胞的特性。包括對患者基因組變化的研究。

對更快藥物開發過程的需求不斷增長推動市場成長

人口老化以及遺傳疾病、慢性病和傳染病發病率的增加使得加速藥物研發進程勢在必行。根據世界衛生組織（WHO）估計，到2050年，60歲及以上的人口預計將增加到21億。在藥物開發過程的發現階段選擇的各種候選藥物由於不利的藥物動力學特性或毒性而未能通過後期階段。人工智慧和機器學習技術可分析藥物對不同遺傳群體的影響並縮短開發時間，從而實現標靶驗證和識別、生物標記發現、藥物再利用和臨床試驗優化。人工智慧模型可以預測針對特定途徑或基因的有效性，刺激不同藥物的效果，並顯示特定患者群體對特定治療的反應。因此，研究人員可以加快藥物開發過程並滿足不斷增長的需求。

基因組計畫投資增加帶動市場需求

各國政府增加對基因組學計畫的投資是推動全球基因組學市場對人工智慧需求的關鍵因素之一，因為人工智慧有助於增強和加速對生成數據的分析。2024年2月，Department of Biotechnology宣佈完成了Genome India Project，並對10,000個基因組進行了定序。全國20家機構收集了99個民族的基因樣本，並創建了可用於未來研究工作的參考基因資料庫。此類投資和舉措正在促進市場的成長，因為它們增強了基因組數據的生成，並且各種人工智慧演算法實現了複雜數據集的有效數據管理和分析。

製藥和生物技術公司佔據主要市場份額

由於遺傳疾病患者數量的增加，製藥和生物技術公司的快速擴張正在支撐市場的成長。American Lung Association估計，美國約有 3 萬人患有囊性纖維化，大約每 30 名美國人中就有 1 名是帶因者。機器學習和人工智慧正在幫助製藥和生物技術公司預測和預防疾病，同時有效管理臨床數據，以預測潛在化合物的毒性並防止其在更有可能失敗的藥物中使用。因此，公司可以投資有效的治療解決方案，改善患者的治療效果。

同時，由於對個人化醫療的投資增加以及更多地採用人工智慧來管理大型數據集，醫院預計在未來幾年將顯著成長。

本報告針對全球基因體學人工智慧市場進行研究分析，提供市場規模與預測、各地區的市場前景、市場動態、競爭格局等。

目錄

第1章 專案範圍與定義

第2章 研究方法

第3章 執行摘要

第4章 基因體學AI市場展望（2017-2031）

  • 市場規模分析與預測
    • 金額
  • 市佔率分析及預測
    • 通過報價
    • 按技術
    • 按功能
    • 按用途
    • 按最終用戶
    • 按地區
    • 市場佔有率分析：按公司劃分（金額）（前 5 名公司及其他 - 2023 年）
  • 市場地圖分析（2023）
    • 通過報價
    • 按技術
    • 按功能
    • 按用途
    • 按最終用戶
    • 按地區

第五章 北美基因體學人工智慧市場展望（2017-2031）

  • 市場規模分析與預測
    • 金額
  • 市佔率分析及預測
    • 通過報價
    • 按技術
    • 按功能
    • 按用途
    • 按最終用戶
    • 分享：按國家/地區
  • 市場評估：依國家分類
    • 美國基因組學人工智慧市場前景（2017-2031）
    • 加拿大
    • 墨西哥

第六章 歐洲基因體學人工智慧市場前景（2017-2031）

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 波蘭

第七章 亞太基因體學人工智慧市場展望（2017-2031）

  • 印度
  • 中國
  • 日本
  • 澳大利亞
  • 越南
  • 韓國
  • 印度尼西亞
  • 菲律賓

第八章 南美洲基因體學AI市場展望（2017-2031）

  • 巴西
  • 阿根廷

第九章 中東與非洲基因體學AI市場展望（2017-2031）

  • 沙烏地阿拉伯
  • 阿拉伯聯合酋長國
  • 南非
  • 以色列

第10章 供需分析

第11章 進出口分析

第12章 價值鏈分析

第13章波特五力分析

第14章 PESTLE分析

第15章 價格分析

第16章 市場動態

  • 市場驅動力
  • 市場課題

第17章 市場趨勢和發展

第18章 監理框架與創新

  • 臨床試驗
  • 監管審批

第19章 專利情況

第20章 案例研究

第21章 競爭格局

  • 前5名市場領導者的競爭矩陣
  • 前5名企業SWOT分析
  • 前10名主要企業狀況
    • Intel Services
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • NVIDIA Corporation
    • Microsoft Corporation
    • International Business Machines Corporation
    • SOPHiA GENETICS
    • BenevolentAI Group
    • Helix, Inc.
    • Deep Genomics Incorporated

第22章 戰略建議

第23章 關於我們公司、免責聲明

Product Code: MX11682

Global AI in genomics market is projected to witness a CAGR of 39.17% during the forecast period 2024-2031, growing from USD 633.60 million in 2023 to USD 8914.51 million in 2031. The market's growth is supported by the advancements in artificial intelligence (AI), rising generation of genomic data, growing requirement for acceleration of drug development processes, increasing cases of chronic diseases, and expansion of geriatric population. The integration of AI with genomics allows the analyses of large amounts of data in an accurate and time efficient manner and AI algorithms aiding in predicting risk of diseases, developing targeted therapies, and identifying genetic mutations, allowing the healthcare professionals to provide enhanced patient care and making informed decisions.

The rising requirement for personalized medicines is another major factor boosting the global AI in genomics market growth as genomic information aids researchers and scientists in studying the individual responses to the drugs while the integration with AI allows for analyses of larger volumes of data in a time efficient manner. The AI algorithms aid in developing targeted therapies, identifying genetic mutations, and predicting the risk of disease.

Additionally, the increasing cases of cancer is another major factor augmenting the global AI in genomics market size. As per the estimates of the National Cancer Institute, approximately 2,001,140 new cases of cancer are expected to be diagnosed in 2024 in the United States. The increase is propelling the efforts towards the research activities, including research in genomic changes in cancer patients to support the development of cancer related drugs that aid in inhibiting enzyme responses responsible for abnormal growth, halting molecular signaling pathways, and blocking characteristics of cancer cells that are responsible for gene expression.

Rising Requirement for Accelerated Drug Development Process Boosts Market Growth

Due to the growth of aging population and rising cases of genetic, chronic, and infectious diseases, the acceleration of drug development process is becoming essential. According to the estimates of the World Health Organization (WHO), the population of individuals of age sixty and above is expected to increase to 2.1 billion, by 2050. Various drug candidates that are selected during the discovery phase of the drug development processes fail to cross late stages due to unfavorable pharmacokinetic properties and toxicity. AI and machine learning technologies aid in target validation and identification, discovery of biomarkers, repurposing of drugs, and optimization of clinical trials by analyzing the effects of drugs on various genetic populations and shortening the development timeline. The AI models can predict the effectiveness of targeting specific pathways and genes, stimulating the effects of different drugs and indicating how a certain group of patients respond to specific treatments. It in turn aids researchers in speeding the drug development process, allowing them to meet the rising requirements.

Increasing Investments Towards Genomic Projects Boosts Market Demand

The rising investments by different governments towards genomics projects is one of the major factors boosting the global AI in genomics market demand as AI aids in enhancing and accelerating the analysis of the generated data. In February 2024, the Department of Biotechnology announced that they had completed the Genome India Project and conducted sequencing of 10,000 genomes. Twenty institutions across the country collected gene samples from ninety-nine ethnic groups, creating a reference of genetic database for utilization in future research activities. Such investments and initiatives are bolstering the generation of genomic data and augmenting the growth of the market as various AI algorithms allow for effective management of data and analysis of complex data sets.

Pharmaceutical and Biotech Companies Hold Significant Market Share

The rapid expansion of pharmaceutical and biotech companies due to the increasing cases of genetic diseases is supporting the market's growth. As per the estimates of the American Lung Association, approximately 30,000 people in the United States have cystic fibrosis, and around 1 in 30 Americans is a carrier. Machine learning and artificial intelligence aid pharmaceutical and biotech companies to automate prediction and prevention of disease, along with efficient management of clinical data that predict toxicity of potential compounds, preventing them from use in drugs that have a higher probability of failing. It in turn will allow the companies to invest in effective therapeutic solutions, thus enhancing the patient outcomes.

Meanwhile, hospitals are expected to witness significant growth in the forecast years, it can be attributed to the rising investments in personalized medicines and rising adoption of AI for management of large data sets.

North America Expected to Hold Significant Market Share

The market growth in North America is supported by the strong presence of research institutions and biotech and genomic companies in the region, coupled with rising investments towards the development of AI powered solutions for applications in genomics. The rising investments in genomics can be attributed to the wide range of applications of the sector in healthcare and possible breakthroughs that could provide a cure for diseases and disorders that were earlier deemed without course or fatal. The rising prevalence of cancer in the region is another major factor, due to which investments in genomics are increasing, which in turn, is providing lucrative growth opportunities for the market. As per the estimates of the National Cancer Institute, 2,001,140 new cases of cancer are expected to be diagnosed in the United States in 2024.

Meanwhile, market is expected to witness significant growth in Asia-Pacific in the forecast years, owing to the increasing government initiatives in the region as genome sequencing in combination with phenotype, microbiome, and clinical information will allow for an enhanced analysis of healthy and disease affected individuals on the basis of inferred local ancestries.

Future Market Scenario (2024 - 2031F)

AI is expected to accelerate the analysis of massive genome sequencing data. The rising investments in research and development activities are expected to support the expansion of the market. The Hospital Universitari Vall d'Hebron Research Institute is conducting an observational study for improving the SCD prognosis and classification by AI. The study aims to advance disease characterization for improving health outcomes by developing individual models in sickle cell disease and identifying biomarkers. The development of the GENOMED4ALL AI algorithm for the sickle cell disease will allow in-depth characterization and the prediction of various complications associated with the disease. The primary endpoints of interest include the development of a probability score for predicting different patterns recognized by AI, development of predictive risk scores for occurrences of severe and prevalent clinical outcomes, and improved sickle cell disease classification. The study is expected to conclude in December 2024.

Key Players Landscape and Outlook

The growth of AI in genomics market is supported by the rising collaborations and partnerships between the key players of the market and leading biotechnology companies. In June 2024, Helix, Inc. announced partnership with Recursion Pharmaceuticals that will combine the company's clinic-genomic dataset with over 25 petabytes of the latter's chemical and biological data. Such collaborations will aid scientists in gathering more information about the correlation between genes and diseases and the availability of genetic information, allowing them to identify patients that could aid from preventive measures or specific treatments. This will aid healthcare professionals and reduce costs related to duplicate testing, resulting in efficient utilization of resources.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global AI in Genomics Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Offering
      • 4.2.1.1. Software
      • 4.2.1.2. Services
    • 4.2.2. By Technology
      • 4.2.2.1. Machine Learning
        • 4.2.2.1.1. Deep Learning
        • 4.2.2.1.2. Supervised Learning
        • 4.2.2.1.3. Unsupervised Learning
        • 4.2.2.1.4. Reinforcement Learning
        • 4.2.2.1.5. Others
      • 4.2.2.2. Computer Vision
    • 4.2.3. By Functionality
      • 4.2.3.1. Genome Sequencing
      • 4.2.3.2. Clinical Workflow
      • 4.2.3.3. Predictive Genetic Testing and Preventive Medicine
      • 4.2.3.4. Gene Editing
    • 4.2.4. By Application
      • 4.2.4.1. Drug Discovery and Development
      • 4.2.4.2. Precision Medicine
      • 4.2.4.3. Diagnostics
      • 4.2.4.4. Agriculture and Animal Research
      • 4.2.4.5. Others
    • 4.2.5. By End-user
      • 4.2.5.1. Pharmaceutical and Biotech Companies
      • 4.2.5.2. Healthcare Providers
      • 4.2.5.3. Research Centers
      • 4.2.5.4. Others
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia-Pacific
      • 4.2.6.4. South America
      • 4.2.6.5. Middle East and Africa
    • 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Offering
    • 4.3.2. By Technology
    • 4.3.3. By Functionality
    • 4.3.4. By Application
    • 4.3.5. By End-user
    • 4.3.6. By Region

5. North America AI in Genomics Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Offering
      • 5.2.1.1. Software
      • 5.2.1.2. Services
    • 5.2.2. By Technology
      • 5.2.2.1. Machine Learning
        • 5.2.2.1.1. Deep Learning
        • 5.2.2.1.2. Supervised Learning
        • 5.2.2.1.3. Unsupervised Learning
        • 5.2.2.1.4. Reinforcement Learning
        • 5.2.2.1.5. Others
      • 5.2.2.2. Computer Vision
    • 5.2.3. By Functionality
      • 5.2.3.1. Genome Sequencing
      • 5.2.3.2. Clinical Workflow
      • 5.2.3.3. Predictive Genetic Testing and Preventive Medicine
      • 5.2.3.4. Gene Editing
    • 5.2.4. By Application
      • 5.2.4.1. Drug Discovery and Development
      • 5.2.4.2. Precision Medicine
      • 5.2.4.3. Diagnostics
      • 5.2.4.4. Agriculture and Animal Research
      • 5.2.4.5. Others
    • 5.2.5. By End-user
      • 5.2.5.1. Pharmaceutical and Biotech Companies
      • 5.2.5.2. Healthcare Providers
      • 5.2.5.3. Research Centers
      • 5.2.5.4. Others
    • 5.2.6. By Country Share
      • 5.2.6.1. United States
      • 5.2.6.2. Canada
      • 5.2.6.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States AI in Genomics Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Offering
          • 5.3.1.2.1.1. Software
          • 5.3.1.2.1.2. Services
        • 5.3.1.2.2. By Technology
          • 5.3.1.2.2.1. Machine Learning
          • 5.3.1.2.2.1.1. Deep Learning
          • 5.3.1.2.2.1.2. Supervised Learning
          • 5.3.1.2.2.1.3. Unsupervised Learning
          • 5.3.1.2.2.1.4. Reinforcement Learning
          • 5.3.1.2.2.1.5. Others
          • 5.3.1.2.2.2. Computer Vision
        • 5.3.1.2.3. By Functionality
          • 5.3.1.2.3.1. Genome Sequencing
          • 5.3.1.2.3.2. Clinical Workflow
          • 5.3.1.2.3.3. Predictive Genetic Testing and Preventive Medicine
          • 5.3.1.2.3.4. Gene Editing
        • 5.3.1.2.4. By Application
          • 5.3.1.2.4.1. Drug Discovery and Development
          • 5.3.1.2.4.2. Precision Medicine
          • 5.3.1.2.4.3. Diagnostics
          • 5.3.1.2.4.4. Agriculture and Animal Research
          • 5.3.1.2.4.5. Others
        • 5.3.1.2.5. By End-user
          • 5.3.1.2.5.1. Pharmaceutical and Biotech Companies
          • 5.3.1.2.5.2. Healthcare Providers
          • 5.3.1.2.5.3. Research Centers
          • 5.3.1.2.5.4. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe AI in Genomics Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific AI in Genomics Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America AI in Genomics Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa AI in Genomics Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Intel Services
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. Illumina, Inc.
    • 21.3.3. Thermo Fisher Scientific Inc.
    • 21.3.4. NVIDIA Corporation
    • 21.3.5. Microsoft Corporation
    • 21.3.6. International Business Machines Corporation
    • 21.3.7. SOPHiA GENETICS
    • 21.3.8. BenevolentAI Group
    • 21.3.9. Helix, Inc.
    • 21.3.10. Deep Genomics Incorporated

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 2. Global AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 3. Global AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 4. Global AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 5. Global AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 6. Global AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global AI in Genomics Market Share (%), By Region, 2017-2031F
  • Figure 8. North America AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 9. North America AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 10. North America AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 11. North America AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 12. North America AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 13. North America AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America AI in Genomics Market Share (%), By Country, 2017-2031F
  • Figure 15. United States AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 16. United States AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 17. United States AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 18. United States AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 19. United States AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 20. United States AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 22. Canada AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 23. Canada AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 24. Canada AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 25. Canada AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 28. Mexico AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 29. Mexico AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 30. Mexico AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 31. Mexico AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 34. Europe AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 35. Europe AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 36. Europe AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 37. Europe AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe AI in Genomics Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 41. Germany AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 42. Germany AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 43. Germany AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 44. Germany AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 46. France AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 47. France AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 48. France AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 49. France AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 50. France AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 51. France AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 53. Italy AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 54. Italy AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 55. Italy AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 56. Italy AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 59. United Kingdom AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 60. United Kingdom AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 61. United Kingdom AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 62. United Kingdom AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 65. Russia AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 66. Russia AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 67. Russia AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 68. Russia AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 71. Netherlands AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 72. Netherlands AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 73. Netherlands AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 74. Netherlands AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 77. Spain AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 78. Spain AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 79. Spain AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 80. Spain AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 83. Turkey AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 84. Turkey AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 85. Turkey AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 86. Turkey AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 89. Poland AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 90. Poland AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 91. Poland AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 92. Poland AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 95. South America AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 96. South America AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 97. South America AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 98. South America AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 99. South America AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America AI in Genomics Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 102. Brazil AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 103. Brazil AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 104. Brazil AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 105. Brazil AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 108. Argentina AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 109. Argentina AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 110. Argentina AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 111. Argentina AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 114. Asia-Pacific AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 115. Asia-Pacific AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 116. Asia-Pacific AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 117. Asia-Pacific AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific AI in Genomics Market Share (%), By Country, 2017-2031F
  • Figure 120. India AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 121. India AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 122. India AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 123. India AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 124. India AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 125. India AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 126. China AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 127. China AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 128. China AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 129. China AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 130. China AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 131. China AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 133. Japan AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 134. Japan AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 135. Japan AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 136. Japan AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 139. Australia AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 140. Australia AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 141. Australia AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 142. Australia AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 145. Vietnam AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 146. Vietnam AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 147. Vietnam AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 148. Vietnam AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 151. South Korea AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 152. South Korea AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 153. South Korea AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 154. South Korea AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 157. Indonesia AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 158. Indonesia AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 159. Indonesia AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 160. Indonesia AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 163. Philippines AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 164. Philippines AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 165. Philippines AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 166. Philippines AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 169. Middle East & Africa AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 170. Middle East & Africa AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 171. Middle East & Africa AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 172. Middle East & Africa AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa AI in Genomics Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 176. Saudi Arabia AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 177. Saudi Arabia AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 178. Saudi Arabia AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 179. Saudi Arabia AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 182. UAE AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 183. UAE AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 184. UAE AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 185. UAE AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa AI in Genomics Market, By Value, In USD Million, 2017-2031F
  • Figure 188. South Africa AI in Genomics Market Share (%), By Offering, 2017-2031F
  • Figure 189. South Africa AI in Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 190. South Africa AI in Genomics Market Share (%), By Functionality, 2017-2031F
  • Figure 191. South Africa AI in Genomics Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa AI in Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Offering Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 194. By Technology Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 195. By Functionality Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 196. By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 197. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 198. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023